Search earnings tickers

REGN

2025Q2BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-08-01 · Fiscal end 2025-06-30 · Features as of 2025-07-31

← Earnings history

Street

Consensus EPS8.44

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.7%

IV front—

P/C full—

P/C front—

Features as of2025-07-31

Run-up

Close—

Ret 5d-3.4%

Ret 10d-0.8%

Ret 20d-0.4%

Ret 30d+7.2%

Print

Actual EPS

12.89Beat

Estimated EPS8.44

Actual revenue

3.7B

Surprise %+52.7%

Beat / missBeat

Beat streak 41

Beat streak 81

Reaction

1-day stock reaction-4.1%

Implied vs actual

Implied 2.7%Actual 6.9%

Gap reaction+6.9%

Day result+2.5%

Next-day upNo

Realized / IV2.59×

Post tape

Post 5d+0.7%

Post 10d+3.9%

Post volume1.7M

Vol ×10d1.83×

Vol ×20d1.88×

Post range6.9%